Characterization of human presenilin 1 transgenic rats: Increased sensitivity to apoptosis in primary neuronal cultures

Neuroscience

Volumn 87, Issue 2, 1998, Pages 325-336

  Czech, C ^a   Lesort, M ^b   Tremp, G ^a   Terro, F ^b   Blanchard, V ^a   Schombert, B ^a   Carpentier, N ^a   Dreisler, S ^b   Bonici, B ^a   Takashima, A ^c   Moussaoui, S ^a   Hugon, J ^b   Pradier, L ^a  

^a SANOFI   (France)

^b Neurbio Cell Pathol U (C   (France)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Apoptosis; HMG CR promoter; Presenilin 1; Primary neuronal culture; Transgenic rats

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; FETUS; GENE MUTATION; GENE OVEREXPRESSION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEURONS; PRESENILIN-1; RATS; RATS, INBRED F344;

EID: 0032551640     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00162-6     Document Type: Article

References (49)

1. Anderson A. J., Su J. H., Cotman C. W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
2. Armstrong D. T., Opavski M. A. Superovulation of immature rats by continuous infusion of follicle-stimulating hormone. Biol. Reprod. 39:1988;511-518.
3. Blanchard V., Czech C., Bonici B., Clavel N., Gohin M., Dalet K., Revah F., Pradier L., Imperato A., Moussaoui S. Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localisation with presenilin 1 protein. Brain Res. 758:1997;209-217.
4. Boissiere F., Pradier L., Delaere P., Faucheux B., Revah F., Brice A., Agid Y., Hirsch E. C. Regional and cellular presenilin 2 (STM2) gene expression in the human brain. NeuroReport. 7:1996;2021-2025.
5. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C. M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., Sisodia S. S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
6. Calenda A., Mestre-Frances N., Czech C., Pradier L., Petter A., Bons N., Bellis M. Molecular cloning, sequencing, and brain expression of the presenilin 1 gene in Microcebus murinus. Biochem. biophys. Res. Commun. 228:1996;430-439.
7. Charreau B., Tesson L., Soulillou J.-P., Pourcel C., I A. Transgenesis in rats: technical aspects and models. Transgen. Res. 5:1996;223-234.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
9. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George-Hyslop H. P., Selkoe D. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [see comments]. Nature Med. 3:1997;67-72.
10. Czech C., Delaere P., Macq A.-F., Reibaud M., Dreisler S., Touchet N., Schomber B., Mazadier M., Mercken L., Theisen M., Pradier L., Octave J.-N., Beyreuther K., Tremp G. L. Proteolytical processing of mutated human amyloid protein precursor in transgenic mice. Molec. Brain Res. 47:1997;108-116.
11. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P. S., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. biol. Chem. 272:1997;3590-3598.
12. Deng G., Pike C. J., Cotman C. W. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. Fedn Eur. biochem. Socs Lett. 397:1996;50-54.
13. Duff K., Eckman C., Zehr C. Yu X., Prada C. M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
14. Elder G. A., Tezapsidis N., Carter J., Shioi J., Bouras C., Li H. C., Johnston J. M., Efthimiopoulos S., Friedrich V. L. J., Robakis N. K. Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J. Neurosci. Res. 45:1996;308-320.
15. Gautier C., Methali M., Lathe R. A ubiquitous mammalian expression vektor, pHMG, based on a housekeeping gene promoter. Nucl. Acids Res. 17:1989;8398.
16. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N., Martin G. M., Mattson M. P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. NeuroReport. 8:1996;379-383.
17. Guo Q., Sopher B. L., Furukawa K., Pham D. G., Robinson N., Martin G. M., Mattson M. P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
18. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
19. Hogan B., Constantini F. and Lacey E. (1986) Manipulating the Mouse Embryo, A Laboratory Manual, Cold Spring Harbour Laboratory, U.S.A.
20. Kim T.-W., Pettingell W., Jung Y.-K., Kovacs D., Tanzi R. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
21. Kovacs D. M., Fausett H. J., Page K. J., Kim T. W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2:1996;224-229.
22. LaFerla F., Troncoso J., Strickland D., Kawas C., Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular A beta stabilization. J. clin. Invest. 100:1997;310-320.
23. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9:1995;21-30.
24. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta neuropath. 89:1995;35-41.
25. Lesort M., Blanchard C., Yardin C., Esclaire F., Hugon J. Cultured neurons expressing phosporylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Molec. Brain Res. 45:1997;127-132.
26. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crawley A. C., Fu Y., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus [see comments]. Science. 269:1995;973-977.
27. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grünberg J., Haass C., Jacobsen H. Presenilins are processed by caspase-type proteases. J. biol. Chem. 272:1997;20655-20659.
28. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y., Noguchi K., Imahori K., Takashima A. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. Fedn Eur. biochem. Socs Lett. 389:1996;297-303.
29. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. Eur. molec. Biol. Org. J. 15:1996;1265-1274.
30. Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M., Imperato A., Revah F. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. Fedn Eur. biochem. Socs Lett. 383:1996;219-222.
31. Pahl H., Baeurle P. Endoplasmatic-reticulum induced signal transduction and gene expression. Trends Cell Biol. 7:1997;50-55.
32. Paul M., Wagner J., Hoffmann S., Urata H., Ganten D. Transgenic rats: new experimental models for the study of candidate genes in hypertension research. A. Rev. Physiol. 56:1994;811-829.
33. Quarteronet D., Pradier L., Czech C., Delalonde L., Burgevin M. C., Doble A., Petitet F. Localization of presenilin-1 mRNA in rat brain. NeuroReport. 7:1996;2587-2591.
34. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Placentini S., Amaducci L., Chumakov I., Cohen D., Lamfelt L., Fraser P. E., Rammens J. M., St George-Hyslop P. H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
35. Schellenberg G. D. Genetic dissection of Alzheimer disease, a heterogeneous disorder. [Review]. Proc. natn. Acad. Sci. U.S.A. 92:1995;8552-8559.
36. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [see comments]. Nature Med. 2:1996;864-870.
37. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease [see comments]. Nature. 375:1995;754-760.
38. Stieber A., Mourelatos Z., Gonatas N. K. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Path. 148:1996;415-426.
39. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
40. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr., Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
41. Thinakaran G., Borchelt D. R., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A. I., Gandy S. E., Jenkins N. A., Copeland N. G., Price D. L., Sisodia S. S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
42. Vito P., Lacana E., D'Adamio L. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 271:1996;521-525.
43. Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacana E. D., Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. biol. Chem. 271:1996;31025-31028.
44. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., Hyslop P. S., Selkoe D. J., Haass C. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Molec. Med. 2:1996;673-691.
45. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C. L., Beyreuther K. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein. Nature Med. 3:1997;328-332.
46. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W. D., Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-3171.
47. Xia W., Zhang J., Perez R., Koo E., Selkoe D. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimers disease. Proc. natn. Acad. Sci. U.S.A. 94:1997;8208-8213.
48. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T. B., Giambarella U., Nishimoto I. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science. 272:1996;1349-1352.
49. Yamatsuji T., Okamoto T., Takeda S., Murayama Y., Tanaka N., Nishimoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. Eur. molec. Biol. Org. J. 15:1996;498-509.